CA Patent

CA2429898C — Devices and methods for cholesterol management

Assigned to Durect Corp · Expires 2011-02-22 · 15y expired

What this patent protects

Implanted, sustained release dosage forms, devices and methods for the delivery of a cholesterol lowering agent.

USPTO Abstract

Implanted, sustained release dosage forms, devices and methods for the delivery of a cholesterol lowering agent.

Drugs covered by this patent

Patent Metadata

Patent number
CA2429898C
Jurisdiction
CA
Classification
—
Expires
2011-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Durect Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.